BMP7 and obesity due to melanocortin 4 receptor deficiency: Furthermore, given the much wider application potential of BMP-7 in conditions with huge global incidence—such as diabetes and obesity for example—pharmaceutical companies investing in BMP-7 will certainly earn significant return on investment.